Today, Family Research Council (FRC), together with Dr. Michael New, Assistant Professor of Social Research at the Busch...
Ingrid Haugen
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro...
(Family Features) Millions of people experience chronic pain, with knee pain among the most common. Athletes and active adults...
Galimedix Therapeutics, Inc. (“Galimedix”), a Phase 2 clinical-stage biotechnology company developing novel oral and topical neuroprotective therapies...
OrthoVentions LLC today announced its investment in MotioOV, an early-stage company created in partnership with the Hospital...
Blue Shield of California Named One of the World’s® Most Ethical Companies for the 12th Time in 2024
2 min read
Blue Shield of California Named One of the World’s® Most Ethical Companies for the 12th Time in 2024
Blue Shield of California was recognized as one of the World’s® Most Ethical Companies in 2024 by Ethisphere, a global...
A preclinical study just published in Advances in Bioscience and Biotechnology demonstrates impressive benefits for skin structure...
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to...
Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”)’s partner Pfizer Inc. (NYSE: PFE) announced that the European Commission...
Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
2 min read
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Ministry of Health, Labor and Welfare...